Skip to main content
Glama

Scan Competitor AI Presence

scan_competitor_ai_presence
Read-onlyIdempotent

Compare AI visibility across multiple entities side-by-side. Probes each entity (your brand + N competitors) with ai_visibility_check, ranks by score, surfaces which is most/least recognized. Useful for competitive AI-marketing audits: "does Claude know about us as well as our competitors?". Returns ranked list with score, confidence, signal density per entity.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
modelsNoWhich models to probe. Supported: "workers-ai" (free default), "anthropic" (requires _apiKey). Omit for just workers-ai.
_apiKeyNoOptional Anthropic API key — only if "anthropic" is in models. Passed to api.anthropic.com per probe.
contextNoOptional shared context applied to every probe (e.g. "B2B SaaS", "Boston restaurant"). Disambiguates common names.
entitiesYesArray of 2-8 entities to compare (brand/business/product names). First entry treated as the "subject" for narrative; rest are competitors.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A4.4/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations (readOnlyHint, idempotentHint, etc.), the description adds valuable behavioral details: it internally calls 'ai_visibility_check' per entity, treats the first entity as the subject, and returns a ranked list with score, confidence, and signal density. It also notes that the 'anthropic' model requires an API key. These enrich the agent's understanding of what the tool does without contradicting annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is extremely concise: 4 sentences that front-load the primary action, explain the mechanism, provide a concrete use case with an example, and summarize the output. Every sentence adds value, and there is no redundancy or fluff.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (4 parameters, no output schema), the description adequately explains the input semantics and output structure ('ranked list with score, confidence, signal density'). It mentions the entity count limit and the optional API key. The only gap is the lack of explicit error handling or edge case behavior, but this is acceptable for a comparison tool with clear annotations.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

While the input schema covers all 4 parameters with descriptions (100% coverage), the description adds context that the 'entities' parameter's first entry is treated as the subject and the rest as competitors. It also explains the purpose of the 'context' parameter (disambiguation) and the 'models' parameter (probe options). This goes beyond the schema alone and helps the agent use the parameters correctly.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description uses specific verbs ('Compare', 'Probes', 'ranks', 'surfaces') and clearly states the tool compares AI visibility across multiple entities, ranks them, and identifies most/least recognized. It explicitly distinguishes itself from the sibling 'ai_visibility_check' by framing it as a multi-entity comparison tool, and the example quote reinforces the competitive audit use case.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides a clear use case ('competitive AI-marketing audits') and an example question, helping agents know when to invoke this tool over alternatives. However, it does not explicitly state when NOT to use it or mention the related sibling 'compare_entities', which could be a potential alternative. The guidance is strong but not exhaustive.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.1/5.0
Disambiguation5/5

Every tool has a clearly distinct purpose, even within the same domain (e.g., ask_pipeworx vs ask_pipeworx_grounded vs ask_pipeworx_beta are differentiated by groundedness/beta status; polymarket_edges vs polymarket_arbitrage vs polymarket_fill_risk each target discovery vs arbitrage vs execution risk). The descriptions are highly detailed, eliminating ambiguity about when to use each.

Naming Consistency4/5

All tool names use snake_case consistently, and most follow a verb-first pattern (ask_, compare_, discover_, search_, validate_), but a few are noun-first (entity_profile, polymarket_edges, recent_alerts). The style is readable and predictable, though not perfectly uniform in the verb_noun convention.

Tool Count2/5

With 37 tools, the server is heavily over-scoped, especially given the 'Pharma Intel' name that suggests a focused pharma domain. Many tools are general-purpose (prediction markets, memory, subscription management, feedback) unrelated to the server's apparent purpose, making it feel like a grab bag rather than a cohesive set.

Completeness4/5

The pharma-specific tools cover drug profiles, safety, pipeline scans, catalysts, indication landscapes, and sponsor diligence – a solid lifecycle coverage. The broader data/query/prediction-market tools also feel complete for their respective sub-domains. The only minor gaps are niche operations (e.g., updating a subscription), but these are not critical to the core workflows.

Resources